These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1429337)

  • 21. Effect of two antibiotics on human granulocyte activities.
    Grant M; Raeburn JA; Sutherland R; Harkness RA; Gormley IP; Kowolik MJ
    J Antimicrob Chemother; 1983 Jun; 11(6):543-54. PubMed ID: 6309730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of in vitro antibacterial activity of four oral cephems: cephalexin, cefaclor, cefatrizine and cefadroxil.
    Luh KT; Chao HP; Ho SW; Hsieh WC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1984 Feb; 17(1):11-8. PubMed ID: 6378550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacodynamic activity of five oral cephalosporins against Haemophilus influenzae.
    Stein GE; Schooley S; Walker RD; Strenkoski-Nix L
    Pharmacotherapy; 1997; 17(2):235-41. PubMed ID: 9085313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ro 15-8075 (cefetamet pivoxyl), a new oral cephalosporin: in vitro activity of the free acid Ro 15-8074 and regression line analyses.
    Grimm K; Grimm H
    Chemioterapia; 1987 Jun; 6(2 Suppl):84-7. PubMed ID: 3509540
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of AC-1370, a new semisynthetic cephalosporin, on phagocyte functions.
    Ohnishi H; Kosuzume H; Inaba H; Okura M; Mochizuki H; Suzuki Y; Fujii R
    Antimicrob Agents Chemother; 1983 Jun; 23(6):874-80. PubMed ID: 6614892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of pentamidine salts on the in-vitro responses of neutrophilic granulocytes.
    Arnott MA; Hay J
    J Antimicrob Chemother; 1989 Apr; 23(4):557-64. PubMed ID: 2663812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparable evaluation of orally active beta-lactam compounds in ampicillin-resistant gram-positive and gram-negative rods: role of beta-lactamases on resistance.
    Cullmann W; Dick W; Stieglitz M; Opferkuch W
    Chemotherapy; 1988; 34(3):202-15. PubMed ID: 3262045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro activity of cefetamet against enterobacteria expressing an SHV-5-type beta-lactamase.
    Tzouvelekis LS; Prinarakis EE; Gazouli M; Miriagou V; Tzelepi E; Legakis NJ
    Chemotherapy; 1996; 42(5):324-8. PubMed ID: 8874970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cefpodoxime proxetil, its in vitro antibacterial activity, affinity to bacterial penicillin-binding proteins, and synergy of bactericidal activity with serum complement and mouse-cultured macrophages.
    Yokota T; Suzuki E; Arai K
    Drugs Exp Clin Res; 1988; 14(8):495-500. PubMed ID: 3073932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preliminary antimicrobial susceptibility interpretive criteria for cefetamet (Ro 15-8074) and cefteram (Ro 19-5247) disk tests.
    Jones RN; Barry AL
    J Clin Microbiol; 1987 Sep; 25(9):1796-9. PubMed ID: 3654953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The effect of cefaclor, doxycycline and other oral antibiotics on phagocytosis of polymorphonuclear granulocytes and PHA-induced stimulation of blood lymphocytes in man].
    Hahn H; Kuhring D; Trautmann M; Diamantstein T
    Arzneimittelforschung; 1985; 35(2):543-6. PubMed ID: 3873244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of thiopental on granulocyte oxidative microbicidal capacity.
    Salo M; Perttilä J
    Acta Anaesthesiol Scand; 1989 May; 33(4):339-42. PubMed ID: 2655368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cefetamet pivoxil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Bryson HM; Brogden RN
    Drugs; 1993 Apr; 45(4):589-621. PubMed ID: 7684677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunomodulating properties of newer cephalosporins: a preliminary classification.
    Labro M; Bryskier A
    Chemioterapia; 1987 Jun; 6(2 Suppl):219-21. PubMed ID: 3334561
    [No Abstract]   [Full Text] [Related]  

  • 35. Third generation oral cephalosporins: comparative in vitro kinetics.
    Speciale A; Blandino G; Nicoletti G
    J Chemother; 1995 May; 7 Suppl 1():9-12. PubMed ID: 8618112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Antibacterial activity of cefpodoxime against clinical isolates in 2000 and 2001].
    Abe T; Fukuoka T; Sato Y; Ito K; Sei M
    Jpn J Antibiot; 2002 Dec; 55(6):827-43. PubMed ID: 12621736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative in vitro antibacterial activities of cefetamet (Ro 15-8074/005), a new oral cephalosporin, and eight other oral antimicrobials.
    Rozgonyi F; Papp-Falusi E; Varga J; Rozgonyi-Szitha K
    J Chemother; 1989 Jul; 1(4 Suppl):119-22. PubMed ID: 16312332
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunopharmacology of oral betalactams.
    Periti P
    J Chemother; 1998 Apr; 10(2):91-6. PubMed ID: 9603632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro and in vivo antibacterial activities of FK037, a new parenteral cephalosporin.
    Nishino T; Otsuki M; Hatano K; Nishihara Y
    Chemotherapy; 1994; 40(3):167-82. PubMed ID: 8205935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cefetamet pivoxil in otitis media.
    Quevedo A; Sossouhounto R; Kissling M
    ORL J Otorhinolaryngol Relat Spec; 1993; 55(2):93-6. PubMed ID: 8446394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.